Serum substitute additive and application thereof
By developing serum replacement additives containing Chinese medicine extracts and a variety of nutrients, combined with basal culture medium, the problems of high cost and insufficient supply of fetal bovine serum are solved, the same cell growth effect as fetal bovine serum is achieved, and production is reduced Cost and experimental uncertainty.
Patent Information
- Application Number
- CN202411182838.7
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-08-27
- Publication Date
- 2024-12-03
AI Technical Summary
Due to the high production and quality requirements, fetal bovine serum has high costs and insufficient supply, which makes it difficult to meet the needs of cell culture. The existing alternatives are uncontrollable and the components are complex, which affects cell growth and experimental reliability.
Develop a full-in ingredient serum replacement additive, containing components such as Chinese medicine extracts, amino acids, proteins, vitamins, inorganic salts, lipids and hormones, combined with basal culture medium, and provide a simplified formula to replace fetal bovine serum to ensure cells Nutritional and growth needs.
The same cell growth and proliferation effects as fetal bovine serum are achieved, the production cost is reduced, the uncertainty of unknown components on cell culture is avoided, the functions of anti-inflammatory, antioxidant and promoting cell proliferation are provided, and the functions of cell culture are met. need.
Smart Images

Figure CN119060934A_ABST
Abstract
Description
Technical Field
[0001] The present invention belongs to the technical field of cell biology, and mainly relates to a serum replacement additive, and in particular to a formula of a replacement additive that meets the cell culture requirements of fetal bovine serum and its application. Background Art
[0002] Fetal bovine serum (FBS) can provide hormones, growth factors, amino acids, proteins, vitamins, inorganic salts, trace elements, carbohydrates, lipids and other nutrients for cell metabolism, growth and proliferation. It has been widely used as a growth additive for cell culture, and the demand for it in industry or scientific research is also growing. However, due to the extremely high requirements for the origin and quality of serum, as well as the production environment and technology, serum that meets the requirements of cell culture has the problems of high cost and limited supply. Therefore, the development of alternative products to FBS, through the addition and use of different types of nutrients in a certain proportion, so that it can still meet the nutritional requirements for cell growth and proliferation, while being controllable in terms of composition and cost, is a current research gap. Summary of the Invention
[0003] Based on this, the main purpose of the present invention is to provide a new, nutrient-rich, easy-to-produce full-component serum replacement preparation that provides nutritional requirements similar to fetal bovine serum for the culture of various cells.
[0004] The present invention mainly relates to the following aspects:
[0005] In one aspect, the present invention provides a serum replacement additive, characterized in that the serum replacement additive comprises a traditional Chinese medicine extract component and an amino acid component, a protein component, a vitamin component, an inorganic salt component, a lipid component, a hormone component, and an auxiliary component:
[0006] The components of the Chinese herbal medicine extract include ginsenosides, baicalein and ligusticum chuanxiongsu (also known as "chuanqiongsu", both of which are the same substance);
[0007] Wherein, the amino acid components include proline, arginine, cysteine, tyrosine, and valine;
[0008] Wherein, the protein components include reduced glutathione, transferrin, insulin and bovine serum albumin;
[0009] Wherein, the vitamin components include vitamin C, vitamin E, vitamin B9, and vitamin B5;
[0010] Wherein, the inorganic salt components include sodium selenite, manganese chloride (tetrahydrate), sodium metavanadate, nickel sulfate (hexahydrate), stannous chloride, and ammonium molybdate (tetrahydrate);
[0011] Wherein, the lipid components include palmitic acid, linoleic acid, oleic acid, and stearic acid;
[0012] Wherein, the hormone components include progesterone, triiodothyronine and corticosterone;
[0013] Wherein, the auxiliary components include coenzyme I, fibronectin, gelatin, polyether F68, and Tween 80.
[0014] Among them, in the aforementioned serum replacement additives,
[0015] The concentration of the aforementioned ginsenosides is 5nM-15nM;
[0016] The concentration of the aforementioned baicalein is 20nM-60nM;
[0017] The concentration of the aforementioned ligustine is 1nM-10nM.
[0018] The amino acid composition comprises proline at a concentration of 92-98 g / L, arginine at a concentration of 20-25 g / L, cysteine at a concentration of 0.1-0.4 g / L, tyrosine at a concentration of 0.2-0.5 g / L, and valine at a concentration of 50-60 g / L.
[0019] Wherein, the concentration of reduced glutathione in the protein component is 160-220 mg / L, the concentration of transferrin is 120-180 mg / L, the concentration of insulin is 50-150 mg / L, and the concentration of bovine serum albumin is 100-200 mg / L;
[0020] Wherein, the concentration of vitamin C in the vitamin component is 550-600 mg / L, the concentration of vitamin E is 8-12 mg / L, the concentration of vitamin B9 is 10-14 mg / L, and the concentration of vitamin B5 is 10-12 mg / L;
[0021] The inorganic salt component comprises sodium selenite at a concentration of 1.4-1.8 mg / L, manganese chloride (tetrahydrate) at a concentration of 0.6-0.9 mg / L, sodium metavanadate at a concentration of 0.15-0.3 mg / L, nickel sulfate (hexahydrate) at a concentration of 0.8-1.5 mg / L, stannous chloride at a concentration of 0.4-0.8 mg / L, and ammonium molybdate (tetrahydrate) at a concentration of 0.3-0.5 mg / L.
[0022] The concentration of palmitic acid in the lipid component is 0.7-0.9 g / L, the concentration of linoleic acid is 0.18-0.36 g / L, the concentration of oleic acid is 0.28-0.4 g / L, and the concentration of stearic acid is 0.48-0.56 g / L.
[0023] The concentration of progesterone in the hormone component is 10-15 μg / L, the concentration of triiodothyronine is 3-8 μg / L, and the concentration of corticosterone is 15-20 μg / L.
[0024] Among them, the concentration of coenzyme I in the auxiliary components is 0.15-0.3 mg / L, the concentration of fibronectin is 40-60 μg / mL, the volume ratio of gelatin to the serum replacement additive is 0.05%-0.2%, the volume ratio of polyether F68 to the serum replacement additive is 0.05%-0.15%, and the volume ratio of Tween 80 to the serum replacement additive is 0.005%-0.05%.
[0025] Among them, in the aforementioned serum replacement additives:
[0026] (1) The amino acid component further comprises: a combination of one or more selected from the group consisting of serine 12-18 g / L, glycine 2-8 g / L, histidine 13-17 g / L, threonine 30-40 g / L, methionine 1-3 g / L, isoleucine 24-28 g / L, leucine 4-6 g / L, phenylalanine 22-28 g / L, alanine 70-80 g / L, tryptophan 2-4 g / L, and lysine 56-60 g / L;
[0027] (2) The above vitamin component further comprises: a combination of one or more selected from the group consisting of vitamin B1 (thiamine hydrochloride) 12-16 mg / L, vitamin B3 (niacin) 7-10 mg / L, and vitamin B7 (biotin) 15-18 mg / L;
[0028] (3) The above-mentioned inorganic salt component further comprises: a combination of one or more selected from the group consisting of cobalt chloride (hexahydrate) 1.3-1.8 mg / L, chromium sulfate (monohydrate) 1.2-1.5 mg / L, sodium fluoride 6-9 mg / L, and sodium silicate 0.5-0.8 mg / L; and / or
[0029] (4) The lipid component further comprises: a combination of one or more selected from the group consisting of 0.47-0.6 g / L of erucic acid, 0.06-0.1 g / L of cholesterol, 0.2-0.45 g / L of docosahexaenoic acid, and 0.28-0.49 g / L of lecithin.
[0030] In another aspect, the present invention provides a serum-free culture medium comprising the aforementioned serum replacement additive and a basal culture medium.
[0031] Among them, the aforementioned basal culture medium includes culture medium for culturing animal cells and culturing microbial cells, preferably DMEM, DMEM / F12, BME, IMDM, MEM, HamF10, RPMI-160, M119, McCoy5A and L15 culture medium, etc.
[0032] Wherein, the volume ratio of the serum replacement additive to the basal culture medium is 1:4-1:15, preferably 1:5 and 1:10.
[0033] In another aspect, the present invention relates to a method for culturing cells, comprising culturing the cells in the aforementioned cell culture medium.
[0034] The cells include cancer cell lines and various primary cells extracted from adult tissues.
[0035] Among them, the cancer cell lines include A549, H69, H460, MCF-7, T-47D, PC-3, LNCaP, HT-29, SW480, HepG2, Huh7, PANC-1, BxPC-3, AGS, SGC-7901, U87-MG, LN-229, U2OS and Saos-2, etc.
[0036] In order to achieve the above object, in a preferred embodiment of the present invention, the culture medium is configured using an optimized solution of serum replacement additives, wherein the formula of the serum replacement additive involved is specifically:
[0037] Chinese herbal extracts:
[0038] The applicable content range of each component is as follows: ginsenoside 5nM-15nM, baicalein 20nM-60nM, ligustrin 1nM-10nM; and the following components:
[0039] 1) Amino acid components
[0040] The applicable content range of each component is as follows: serine 12-18 g / L, glycine 2-8 g / L, histidine 13-17 g / L, threonine 30-40 g / L, proline 92-98 g / L, arginine 20-25 g / L, cysteine 0.1-0.4 g / L, tyrosine 0.2-0.5 g / L, valine 50-60 g / L, methionine 1-3 g / L, isoleucine 24-28 g / L, leucine 4-6 g / L, phenylalanine 22-28 g / L, alanine 70-80 g / L, tryptophan 2-4 g / L, and lysine 56-60 g / L.
[0041] 2) Protein components
[0042] The applicable content range of each component is as follows: reduced glutathione 160-220 mg / L, transferrin 120-180 mg / L, insulin 50-150 mg / L, and bovine serum albumin 100-200 mg / L.
[0043] 3) Vitamin components
[0044] The applicable content range of each component is as follows: vitamin B1 (thiamine hydrochloride) 12-16 mg / L, vitamin C (L-ascorbic acid 2-phosphate) 550-600 mg / L, vitamin E (tocopheryl acetate) 8-12 mg / L, vitamin B9 (folic acid) 10-14 mg / L, vitamin B5 (pantothenic acid) 10-12 mg / L, vitamin B3 (niacin) 7-10 mg / L, and vitamin B7 (biotin) 15-18 mg / L.
[0045] 4) Inorganic salt components
[0046] The applicable content range of each component is as follows: sodium selenite 1.4-1.8 mg / L, manganese chloride (tetrahydrate) 0.6-0.9 mg / L, sodium metavanadate 0.15-0.3 mg / L, nickel sulfate (hexahydrate) 0.8-1.5 mg / L, stannous chloride 0.4-0.8 mg / L, ammonium molybdate (tetrahydrate) 0.3-0.5 mg / L, cobalt chloride (hexahydrate) 1.3-1.8 mg / L, chromium sulfate (monohydrate) 1.2-1.5 mg / L, sodium fluoride 6-9 mg / L, and sodium silicate 0.5-0.8 mg / L.
[0047] 5) Lipid components
[0048] The applicable content range of each component is as follows: palmitic acid 0.7-0.9 g / L, linoleic acid 0.18-0.36 g / L, oleic acid 0.28-0.4 g / L, stearic acid 0.48-0.56 g / L, erucic acid 0.47-0.6 g / L, cholesterol 0.06-0.1 g / L, docosahexaenoic acid 0.2-0.45 g / L, and lecithin 0.28-0.49 g / L.
[0049] 6) Hormone components
[0050] The applicable content range of each component is as follows: progesterone 10-15 μg / L, triiodothyronine 3-8 μg / L, and corticosterone 15-20 μg / L.
[0051] 7) Auxiliary components
[0052] The cosolvents polyether F68 and Tween 80 are added at a ratio of 0.1% and 0.01% respectively; the adhesive promoters fibronectin and gelatin 40-60 μg / mL are added at a ratio of 0.05%-0.2% respectively; and coenzyme I 0.15-0.3 mg / L is added.
[0053] For a more optimized solution, the concentrations of the above different components can be set as follows:
[0054] Chinese herbal medicine extracts: ginsenoside 5nM-10nM, baicalein 20nM-30nM, ligustrine 1nM-5nM.
[0055] Amino acids: Serine 14-16g / L, Glycine 4-6g / L, Histidine 15-17g / L, Threonine 35-39g / L, Proline 92-96g / L, Arginine 22-25g / L, Cysteine 0.2-0.4g / L, Tyrosine 0.3-0.5g / L, Valine 52-58g / L, Methionine 2-3g / L, Isoleucine 25-28g / L, Leucine 5-6g / L, Phenylalanine 25-28g / L, Alanine 74-77g / L, Tryptophan 3-4g / L, Lysine 58-60g / L
[0056] Proteins: Reduced glutathione 180-200 mg / L, transferrin 140-170 mg / L, insulin 100-120 mg / L, bovine serum albumin 150-200 mg / L
[0057] Vitamins: Vitamin B1 (thiamine hydrochloride) 13-15 mg / L, Vitamin C (L-ascorbic acid 2-phosphate) 570-590 mg / L, Vitamin E (tocopheryl acetate) 10-12 mg / L, Vitamin B9 (folic acid) 12-14 mg / L, Vitamin B5 (pantothenic acid) 11-12 mg / L, Vitamin B3 (niacin) 8-9 mg / L, Vitamin B7 (biotin) 16-18 mg / L
[0058] Inorganic salts: sodium selenite 1.5-1.7 mg / L, manganese chloride (tetrahydrate) 0.72-0.83 mg / L, sodium metavanadate 0.18-0.25 mg / L, nickel sulfate (hexahydrate) 1-1.3 mg / L, stannous chloride 0.5-0.7 mg / L, ammonium molybdate (tetrahydrate) 0.38-0.45 mg / L, cobalt chloride (hexahydrate) 1.3-1.5 mg / L, chromium sulfate (monohydrate) 1.25-1.45 mg / L, sodium fluoride 7-8.5 mg / L, sodium silicate 0.6-0.8 mg / L.
[0059] Lipids: Palmitic acid 0.74-0.86g / L, linoleic acid 0.2-0.32g / L, oleic acid 0.3-0.4g / L, stearic acid 0.5-0.54g / L, erucic acid 0.5-0.6g / L, cholesterol 0.07-0.09g / L, docosahexaenoic acid 0.3-0.42g / L, lecithin 0.3-0.45g / L.
[0060] Hormones: progesterone 11-13μg / L, triiodothyronine 5-6μg / L, corticosterone 16-18μg / L.
[0061] In addition, in the preparation system, 0.1% polyether F68 and 0.01% Tween 80 are added as cosolvents; 0.08-0.15% fibronectin and 45-55 μg / mL gelatin are added as adhesion promoters; and 0.2-0.3 mg / L coenzyme I is added as a coenzyme agent.
[0062] In an optimized solution, the serum replacement additive of the present invention needs to be used in combination with the basal medium required for the target cell culture;
[0063] In a more optimized solution, the volume ratio of the serum replacement additive to the basal culture medium in the present invention is 1:4-1:15;
[0064] In a more optimized solution, the volume ratio of the serum replacement additive to the basal culture medium in the present invention can be specifically set to 1:10.
[0065] Compared with the prior art (containing FBS culture medium), the beneficial effects achieved by the present invention are:
[0066] The serum replacement additive developed by the present invention combines various components necessary for cell growth and proliferation, such as amino acids, proteins, vitamins, inorganic salts, lipids, and hormones, in a defined and well-defined concentration. It also incorporates extracts of traditional Chinese medicines, such as ginsenosides, baicalein, and ligustrin. While providing the nutrients and environment required for cell culture, it also promotes the secretion of insulin and other related growth factors, thereby promoting cell proliferation, and provides anti-inflammatory and antioxidant benefits, thereby ensuring cell health and nutritional status. Therefore, it can completely replace, or even surpass, fetal bovine serum. This helps overcome the current problem of over-reliance on serum in industrial production and scientific research, which is limited in source and has variable quality.
[0067] The serum replacement additive of the present invention contains various cell culture components in a simplified formula, without any additional components that duplicate or conflict with other functions. This simple composition makes preparation easier and reduces costs. Furthermore, unlike the unknown components in fetal bovine serum that can affect cell culture and increase experimental uncertainty, the serum replacement additive of the present invention avoids this issue and the corresponding batch variability.
[0068] The serum replacement additive in the present invention can be used with the basal culture medium required for target cell culture to meet their nutrition, growth and proliferation requirements. In particular, its use can achieve culture results similar to those using fetal bovine serum as a culture additive under the same conditions, meeting the needs of cell culture. BRIEF DESCRIPTION OF THE DRAWINGS
[0069] The accompanying drawings are used to provide a further understanding of the present invention and constitute a part of the specification. Together with the embodiments of the present invention, they are used to explain the present invention and do not constitute a limitation of the present invention. In the accompanying drawings:
[0070] FIG1 shows the effects of the lack of corresponding key components on the culture of 293T cells (a) and A549 cells (b) in Example 1 of the present invention.
[0071] Figure 2 The fluorescence staining diagram shows the proliferation level of 293T cells under three different concentrations in Example 1 of the present invention.
[0072] Figure 3 This is to demonstrate the effects of different serum replacement additive usage ratios on 293T cell viability in Example 2 of the present invention.
[0073] Figure 4 This is to show the effects of the presence or absence of components of the Chinese herbal extract on the oxidation and inflammation levels and insulin growth factor secretion of 293T cells in Example 3 of the present invention.
[0074] Figure 5 This is to demonstrate the effect of the presence or absence of components of the Chinese herbal extract on the proliferation ability and level of 293T cells in Example 3 of the present invention.
[0075] Figure 6 The cell morphology of 293T cells after being cultured in culture medium A (10 mL serum replacement additive + 90 mL DMEM) and B (10 mL fetal bovine serum FBS + 90 mL DMEM) for 3 days in Example 4 of the present invention is shown.
[0076] Figure 7 The cell morphology of 293T cells after being cultured in culture medium A (10 mL serum replacement additive + 90 mL DMEM) and culture medium B (10 mL fetal bovine serum FBS + 90 mL DMEM) for 6 days in Example 4 of the present invention is shown.
[0077] Figure 8 The cell morphology of A549 cells after being cultured for 3 days in culture medium C (10 mL serum replacement additive + 90 mL DMEM / F12) and culture medium D (10 mL fetal bovine serum FBS + 90 mL DMEM / F12) in Example 5 of the present invention is shown.
[0078] Figure 9 The cell morphology of A549 cells after being cultured in culture medium C (10 mL serum replacement additive + 90 mL DMEM / F12) and culture medium D (10 mL fetal bovine serum FBS + 90 mL DMEM / F12) for 6 days in Example 5 of the present invention is shown.
[0079] FIG10 shows the cell number and survival rate (a) and the expression level of cell proliferation genes (b) of 293T cells after culturing in culture media A and B for 6 days in Example 6 of the present invention.
[0080] FIG11 shows the cell number and survival rate (a) and the expression level of cell proliferation genes (b) of A549 cells after being cultured in culture media C and D for 6 days in Example 6 of the present invention. DETAILED DESCRIPTION
[0081] To make the objectives, technical solutions, and advantages of the present invention more clearly understood, the present invention is further described in detail below in conjunction with specific embodiments and with reference to the accompanying drawings. Specifically, according to the embodiments of the present invention, two culture protocols for 293T cells (Mesen cells, CTCC-001-0188) and A549 cells (Mesen cells, CTCC-001-0036) are provided. It should be noted that the following specific embodiments are merely illustrative and the scope of protection of the present invention is not limited thereto.
[0082] Unless otherwise specified, the methods in the following examples are conventional methods, and the drugs or reagents used are commercially available or prepared in-house by known preparation methods.
[0083] Example 1: Preparation of serum replacement additives
[0084] 1. Preparation and effect of serum replacement supplement basic program
[0085] To illustrate the indispensability of various key additive components in the present invention, based on the same initial cell seeding density (5000 cells / well), the medium additives were prepared according to the serum replacement additive basic scheme (Table 1), and the control group lacking the corresponding key components was prepared at the same concentration. 293T cells were cultured at 37°C ( Figure 1a ) and A549 cells ( Figure 1b ), cultured for 6 days, and observed the cell number and morphology.
[0086] Table 1 Basic scheme of serum replacement additives
[0087]
[0088]
[0089]
[0090] The results shown in Figure 1 indicate that the basic serum replacement additive solution provided by the present invention can meet the conditions required for cell growth. While achieving similar results to conventional fetal bovine serum culture, it also verifies that the essential components of the serum replacement additive provided by the present invention are indispensable. Among them, the lack of key components such as lipids, proteins, and amino acids will mainly lead to impeded cell growth and proliferation, resulting in a low cell count; the lack of key components such as vitamins, inorganic salts, and hormones will lead to poor cell status and an increase in the number of stress aggregations; and the lack of adhesion promoter components will lead to a decrease in cell count due to weakened cell adhesion.
[0091] 2. Preparation and Effect of Serum Replacement Additive Optimization Program
[0092] To better highlight the effects of the present invention, in this embodiment, a preferred solution of serum replacement additives (see table below) was selected to prepare the culture medium. Three preparation schemes were set according to the preferred concentrations of various nutrients, as shown in the following table: concentration 1, concentration 2, and concentration 3, respectively covering the unspecific concentration (concentration 2) and endpoint concentrations (concentrations 1 and 3) in the preferred concentration range:
[0093]
[0094]
[0095]
[0096] To illustrate the effectiveness of the three concentration ranges set above in cell culture, the three additives at different concentrations were used in 293T cell culture at the same state and density at a ratio of 10%. After 24 hours, the EdU-488 cell proliferation detection kit (Biyuntian, C0071S) was used to detect the cell proliferation levels under the three conditions. Figure 2 As shown, there is no obvious difference, which illustrates the feasibility of the preferred concentration involved in the invention.
[0097] Example 2: Determination of the preferred addition ratio of serum replacement additives
[0098] To further clarify the preferred addition ratio of the additives in the present invention, 293T cells (Mesen cells, CTCC-001-0188) were used as the experimental subjects, and the basal culture medium was set to DMEM (GIBCO, 11965092) high-glucose medium. Fetal bovine serum or serum replacement additives were mixed with the corresponding volume of basal culture medium at a ratio of 1:4 (25%), 1:5 (20%), 1:10 (10%), and 1:15 (6.7%), respectively. The cells were cultured in 96-well plates of 293T cells (initial seeding volume: 5000 cells / well). After 24 hours, the cells were photographed under a microscope and the absorbance value was detected by Alamar Blue resazurin indicator to calculate the cell viability under different conditions.
[0099] Depend on Figure 3 The test results show that the use of different ratios of FBS (Thermo Fisher, A5669701) or the additive of the present invention does not significantly affect the viability of 293T cells. Relatively speaking, the use of 10% serum replacement additive has a slight improvement effect, so this condition was selected as the experimental plan for subsequent cell culture.
[0100] Example 3: Effect of Chinese herbal supplements on the function of serum replacement additives
[0101] To further illustrate the effects and advantages of the present invention, an experiment was also conducted using 293T cells as an example. Additives containing Chinese herbal extracts and additives without Chinese herbal extracts were prepared in DMEM culture medium at a ratio of 10%. After culturing for 24 hours, protein immunoblotting was used to detect changes in the expression of superoxide dismutase SOD (marker of antioxidant levels) (Abcam, ab308181), interleukin IL-1β (marker of inflammatory levels) (Abcam, ab28381), and insulin growth factor IGF-1 (marker of cell growth activity levels) (Abcam, ab133542). Flow cytometry (Agilent) was also used to analyze the cell cycle under culture conditions with and without Chinese herbal extracts, and the proportion of cells in the DNA synthesis phase (S phase) was detected.
[0102] Depend on Figure 4 The results show that the addition of Chinese herbal extracts increased the expression levels of IGF-1 (about 10%) and SOD (about 30%) while reducing the expression level of IL-1β (about 20%). Figure 5The results show that the addition of Chinese herbal extracts can also promote cells in the G1 phase (first interphase) to enter the G2 phase (second interphase) and S phase (DNA synthesis phase) more quickly. Accordingly, the proportion of cells in the G1 phase decreases, while the proportions of cells in the S and G2 phases increase. Specifically, the proportion of cells in the S phase increases by approximately 10%, thereby better promoting cell proliferation. These results demonstrate that the full-ingredient serum replacement additive provided by the present invention can exert effective cell nutrition, proliferation-promoting effects, and anti-inflammatory and antioxidant effects during cell culture.
[0103] Example 4: Serum replacement supplement for 293T cell culture protocol
[0104] Specifically, the following steps S1-S3 are included, wherein the fetal bovine serum used is a commercially available product (Thermo Fisher, A5669701):
[0105] Step S1: Prepare medium A: 10 mL serum replacement additive (of the present invention) + 90 mL DMEM high glucose medium; prepare medium B: 10 mL fetal bovine serum FBS + 90 mL DMEM high glucose medium.
[0106] Step S2: Take 293T cells with good growth status and cell confluence of about 90%, aspirate the waste liquid, wash with DPBS, add an appropriate amount of 0.05% trypsin, digest for about 20 seconds, add serum-containing DMEM high-glucose medium to terminate the digestion, transfer the cell suspension to a centrifuge tube, and centrifuge for 5 minutes. Then, resuspend with A and B culture media at the same density, transfer to a new culture dish, mix well, and move into the incubator.
[0107] Step S3: Following the seeding of the plate the day before, the culture medium was changed every day to observe the cell status, and photos were taken and recorded on the third and sixth days.
[0108] The results of microscopic observation ( Figure 6 、 7 ) It can be seen that the culture medium prepared by the full-component serum replacement additive provided by the present invention and the FBS-supplemented culture medium have the same culture effect on 293T cells.
[0109] Example 5: Serum replacement supplement for A549 cell culture protocol
[0110] Specifically including the following steps S1-S3:
[0111] Step S1: Prepare medium C: 10 mL serum replacement supplement + 90 mL DMEM / F12 medium (GIBCO, C11330500BT); prepare medium D: 10 mL fetal bovine serum (FBS) + 90 mL DMEM / F12 medium.
[0112] Step S2: Take A549 cells with good growth status and cell confluence of about 90%, aspirate the waste liquid, wash with DPBS, add an appropriate amount of 0.05% trypsin, and digest for about 90 seconds. Add serum-containing DMEM / F12 medium to terminate the digestion. Transfer the cell suspension to a centrifuge tube and centrifuge for 5 minutes. Then, resuspend it in C and D culture media at the same density, transfer it to a new culture dish, mix it evenly, and move it into the incubator.
[0113] Step S3: Following plating the day before, the culture medium was changed every day and the morphology and condition of the cells were observed, and photographs were taken on the third and sixth days.
[0114] The results of microscopic observation ( Figure 8 、 9 ) It can be seen that the culture medium prepared by the full serum replacement additive provided by the present invention and the FBS-supplemented culture medium have the same culture effect on A549 cells.
[0115] Example 6: Experimental detection of 293T and A549 cells after 6 days of culture with serum replacement additives
[0116] 1) Detect cell viability and number
[0117] The cells were divided into two groups. One group was incubated with DMEM / F12 medium containing 10% alamar blue at 37°C for 2 hours and then detected using a microplate reader (Thermo Fisher Scientific) under the following detection conditions: excitation wavelength 530 nm, emission wavelength 590 nm. The percentage of viable cells under different conditions was obtained. After the other group of cells were trypsinized into single cells, a portion of the volume (e.g., 20 μL) was taken and mixed with trypan blue solution in a 1:1 ratio, and the number of viable cells was counted using an automatic cell counter (Thermo Fisher Scientific). Figure 10a 、 11a ).
[0118] 2) Detect the expression changes of genes Ki-67 and PCNA that mark cell proliferation level
[0119] After collecting samples using Trizol reagent (Thermo Fisher, 15596026CN), RNA was extracted and reverse transcribed (refer to Pattern R. RNA isolation and reverse transcription protocol: Cellsin culture [J]. Boston: Abcam, 2019.). The obtained samples were subjected to real-time fluorescence quantitative PCR detection (refer to Doak SH, Z M. Real-time reverse-transcription polymerase chain reaction: technical considerations for gene expression analysis [J]. Genetic Toxicology: Principles and Methods, 2012: 251-270.). Detection of Ki-67 and PCNA gene expression ( Figure 10b 、 11b The primers used were synthesized by Thermo Fisher Scientific, and their sequences are shown in SEQ ID NO. 1-4 in the following table.
[0120] Sequence number Primers sequence SEQ ID NO.1 Ki67-F GGATCGTCCCAGTGGAAGAG SEQ ID NO.2 Ki67-R GTCTCGTGGGCCACATTTTC SEQ ID NO.3 PCNA-F GCTCTTCCCTTACGCAAGTCT SEQ ID NO.4 PCNA-R AGTCTAGCTGGTTTCGGCTT
[0121] Depend on Figure 6 The test results in Figure 11 demonstrate that, compared to conventional culture supplemented with fetal bovine serum, the serum replacement additive of the present invention can enhance cell proliferation and growth while maintaining similar or slightly higher cell survival rates. Therefore, the serum replacement additive of the present invention is fully capable of replacing the functionality of conventional fetal bovine serum.
[0122] In summary, the full-component serum replacement additive provided by the present invention can be used in a wide range of concentrations and in appropriate proportions with basal culture media to meet the nutritional needs of various cells for conventional fetal bovine serum, achieving culture effects equivalent to (or superior to) FBS, specifically including measures of cell morphology, cell number, cell survival rate, cell proliferation level, and other aspects. In addition, the unique traditional Chinese medicine ingredients of the present invention can exert anti-inflammatory, antioxidant, cell nutrition, and proliferation-promoting effects, providing a new case study for the use of traditional Chinese medicine ingredients in cell culture.
[0123] The specific embodiments described above further illustrate the objectives, technical solutions and beneficial effects of the present invention in detail. It should be understood that the above are only specific embodiments of the present invention and are not intended to limit the present invention. Any modifications, equivalent substitutions, improvements, etc. made within the spirit and principles of the present invention should be included in the scope of protection of the present invention.
Claims
1. A serum replacement supplement, characterized in that The serum replacement additive comprises a Chinese medicine extract component and an amino acid component, a protein component, a vitamin component, an inorganic salt component, a lipid component, a hormone component, and an auxiliary component: Wherein, the components of the Chinese herbal medicine extract include ginsenoside, baicalein and ligustrin; Wherein, the amino acid components include proline, arginine, cysteine, tyrosine, and valine; Wherein, the protein components include reduced glutathione, transferrin, insulin and bovine serum albumin; Wherein, the vitamin components include vitamin C, vitamin E, vitamin B9, and vitamin B5; Wherein, the inorganic salt component includes sodium selenite, manganese chloride (tetrahydrate), sodium metavanadate, nickel sulfate (hexahydrate), stannous chloride, and ammonium molybdate (tetrahydrate); Wherein, the lipid components include palmitic acid, linoleic acid, oleic acid, and stearic acid; Wherein, the hormone components include progesterone, triiodothyronine and corticosterone; Wherein, the auxiliary components include coenzyme I, fibronectin, gelatin, polyether F68, and Tween 80.
2. The serum replacement additive according to claim 1, wherein In the serum replacement supplement, The concentration of the ginsenoside is 5nM-15nM; The concentration of baicalein is 20nM-60nM; The concentration of ligustine is 1nM-10nM.
3. The serum replacement additive according to claim 1, in, The amino acid component has a proline concentration of 92-98 g / L, an arginine concentration of 20-25 g / L, a cysteine concentration of 0.1-0.4 g / L, a tyrosine concentration of 0.2-0.5 g / L, and a valine concentration of 50-60 g / L; Wherein, the concentration of reduced glutathione in the protein component is 160-220 mg / L, the concentration of transferrin is 120-180 mg / L, the concentration of insulin is 50-150 mg / L, and the concentration of bovine serum albumin is 100-200 mg / L; Wherein, the concentration of vitamin C in the vitamin component is 550-600 mg / L, the concentration of vitamin E is 8-12 mg / L, the concentration of vitamin B9 is 10-14 mg / L, and the concentration of vitamin B5 is 10-12 mg / L; The inorganic salt component has a sodium selenite concentration of 1.4-1.8 mg / L, a manganese chloride (tetrahydrate) concentration of 0.6-0.9 mg / L, a sodium metavanadate concentration of 0.15-0.3 mg / L, a nickel sulfate (hexahydrate) concentration of 0.8-1.5 mg / L, a stannous chloride concentration of 0.4-0.8 mg / L, and an ammonium molybdate (tetrahydrate) concentration of 0.3-0.5 mg / L. Among them, the concentration of palmitic acid in the lipid component is 0.7-0.9 g / L, the concentration of linoleic acid is 0.18-0.36 g / L, the concentration of oleic acid is 0.28-0.4 g / L, and the concentration of stearic acid is 0.48-0.56 g / L; Wherein, the concentration of progesterone in the hormone component is 10-15 μg / L, the concentration of triiodothyronine is 3-8 μg / L, and the concentration of corticosterone is 15-20 μg / L; Among them, the concentration of coenzyme I in the auxiliary components is 0.15-0.3 mg / L, the concentration of fibronectin is 40-60 μg / mL, the volume ratio of gelatin to the serum replacement additive is 0.05%-0.2%, the volume ratio of polyether F68 to the serum replacement additive is 0.05%-0.15%, and the volume ratio of Tween 80 to the serum replacement additive is 0.005%-0.05%.
4. The serum replacement additive according to claims 1-3, wherein: (1) The amino acid component further comprises: a combination of one or more selected from the group consisting of serine 12-18 g / L, glycine 2-8 g / L, histidine 13-17 g / L, threonine 30-40 g / L, methionine 1-3 g / L, isoleucine 24-28 g / L, leucine 4-6 g / L, phenylalanine 22-28 g / L, alanine 70-80 g / L, tryptophan 2-4 g / L, and lysine 56-60 g / L; (2) The vitamin component further comprises: a combination of one or more selected from vitamin B1 (thiamine hydrochloride) 12-16 mg / L, vitamin B3 (niacin) 7-10 mg / L, and vitamin B7 (biotin) 15-18 mg / L; (3) The inorganic salt component further comprises: a combination of one or more selected from the group consisting of cobalt chloride (hexahydrate) 1.3-1.8 mg / L, chromium sulfate (monohydrate) 1.2-1.5 mg / L, sodium fluoride 6-9 mg / L, and sodium silicate 0.5-0.8 mg / L; and / or (4) The lipid component further comprises: a combination of one or more selected from erucic acid 0.47-0.6 g / L, cholesterol 0.06-0.1 g / L, docosahexaenoic acid 0.2-0.45 g / L and lecithin 0.28-0.49 g / L.
5. A serum-free cell culture medium comprising the serum replacement additive according to any one of claims 1 to 4 and a basal culture medium.
6. The culture medium according to claim 5, wherein The basic culture medium includes culture medium for culturing animal cells and culturing microbial cells, preferably DMEM, DMEM / F12, BME, IMDM, MEM, HamF10, RPMI-160, M119, McCoy5A and L15 culture medium.
7. The cell culture medium according to claim 5 or 6, wherein The volume ratio of the serum replacement additive to the basal culture medium is 1:4-1:15, preferably 1:5 and 1:
10.
8. A method for culturing cells, comprising culturing the cells in the cell culture medium according to any one of claims 5 to 7.
9. The method according to claim 8, wherein: The cells include cancer cell lines, as well as primary cells extracted from adult tissues.
10. The method according to claim 9, wherein: The cancer cell lines include A549, H69, H460, MCF-7, T-47D, PC-3, LNCaP, HT-29, SW480, HepG2, Huh7, PANC-1, BxPC-3, AGS, SGC-7901, U87-MG, LN-229, U2OS and Saos-2.
